VHT holdings (2026)
All 401 positions in Vanguard Health Care ETF, ranked by portfolio weight — led by LLY at 13.8%. Weights come from the fund's own SEC N-PORT filing and update daily with prices; positions in stocks ChartRow doesn't track still appear, ranked by weight, without returns. Not investment advice.
Weights are the May 31, 2026 SEC filing rolled forward on each holding's price move (as of market close, Aug 13, 2026) — an estimate of today, not the filed figure. Switch the table below to see them exactly as filed.
Top 10 holdings#
Sector weights#
Estimated portfolio characteristics#
Estimated by our own bottom-up analysis of the fund's SEC-filed holdings, covering 93% of portfolio weight (92% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
VHT holdings by weight#
101–200 of 401| # | Company | Weight | Price | 1D | YTD | 1Y | Mkt cap |
|---|---|---|---|---|---|---|---|
| 101 | Vaxcyte Inc | 0.09% | — | — | — | — | — |
| 102 | Chemed Corp | 0.09% | — | — | — | — | — |
| 103 | Bio-Rad Laboratories Inc | 0.08% | — | — | — | — | — |
| 104 | TG Therapeutics Inc | 0.08% | — | — | — | — | — |
| 105 | Teleflex Inc | 0.08% | — | — | — | — | — |
| 106 | PTC Therapeutics Inc | 0.08% | — | — | — | — | — |
| 107 | Hims & Hers Health Inc | 0.07% | — | — | — | — | — |
| 108 | APGEApogee Therapeutics Inc. | 0.07% | $134.42 | -0.1% | +78.1% | +266.3% | $10B |
| 109 | Rhythm Pharmaceuticals Inc | 0.07% | — | — | — | — | — |
| 110 | Protagonist Therapeutics Inc | 0.07% | — | — | — | — | — |
| 111 | Tempus AI Inc | 0.07% | — | — | — | — | — |
| 112 | Ligand Pharmaceuticals Inc | 0.06% | — | — | — | — | — |
| 113 | Nuvalent Inc | 0.06% | — | — | — | — | — |
| 114 | Sotera Health Co | 0.06% | — | — | — | — | — |
| 115 | LivaNova PLC | 0.06% | — | — | — | — | — |
| 116 | Twist Bioscience Corp | 0.06% | — | — | — | — | — |
| 117 | Travere Therapeutics Inc | 0.06% | — | — | — | — | — |
| 118 | Envista Holdings Corp | 0.06% | — | — | — | — | — |
| 119 | Kymera Therapeutics Inc | 0.05% | — | — | — | — | — |
| 120 | Mirum Pharmaceuticals Inc | 0.05% | — | — | — | — | — |
| 121 | Indivior Pharmaceuticals Inc | 0.05% | — | — | — | — | — |
| 122 | Liquidia Corp | 0.05% | — | — | — | — | — |
| 123 | Merit Medical Systems Inc | 0.05% | — | — | — | — | — |
| 124 | IRhythm Holdings Inc | 0.05% | — | — | — | — | — |
| 125 | RadNet Inc | 0.05% | — | — | — | — | — |
| 126 | Veracyte Inc | 0.05% | — | — | — | — | — |
| 127 | Catalyst Pharmaceuticals Inc | 0.05% | — | — | — | — | — |
| 128 | Spyre Therapeutics Inc | 0.05% | — | — | — | — | — |
| 129 | Viking Therapeutics Inc | 0.05% | — | — | — | — | — |
| 130 | Organon & Co | 0.05% | — | — | — | — | — |
| 131 | Option Care Health Inc | 0.05% | — | — | — | — | — |
| 132 | Dianthus Therapeutics Inc | 0.05% | — | — | — | — | — |
| 133 | ICU Medical Inc | 0.05% | — | — | — | — | — |
| 134 | Crinetics Pharmaceuticals Inc | 0.04% | — | — | — | — | — |
| 135 | Haemonetics Corp | 0.04% | — | — | — | — | — |
| 136 | Integer Holdings Corp | 0.04% | — | — | — | — | — |
| 137 | Scholar Rock Holding Corp | 0.04% | — | — | — | — | — |
| 138 | Beam Therapeutics Inc | 0.04% | — | — | — | — | — |
| 139 | 10X Genomics Inc | 0.04% | — | — | — | — | — |
| 140 | Cogent Biosciences Inc | 0.04% | — | — | — | — | — |
| 141 | Denali Therapeutics Inc | 0.04% | — | — | — | — | — |
| 142 | Brookdale Senior Living Inc | 0.04% | — | — | — | — | — |
| 143 | Concentra Group Holdings Parent Inc | 0.04% | — | — | — | — | — |
| 144 | Celcuity Inc | 0.04% | — | — | — | — | — |
| 145 | Immunovant Inc | 0.04% | — | — | — | — | — |
| 146 | CG oncology Inc | 0.04% | — | — | — | — | — |
| 147 | Supernus Pharmaceuticals Inc | 0.04% | — | — | — | — | — |
| 148 | Doximity Inc | 0.04% | — | — | — | — | — |
| 149 | ImmunityBio Inc | 0.04% | — | — | — | — | — |
| 150 | Alignment Healthcare Inc | 0.04% | — | — | — | — | — |
| 151 | ACADIA Pharmaceuticals Inc | 0.04% | — | — | — | — | — |
| 152 | GRAIL Inc | 0.04% | — | — | — | — | — |
| 153 | National HealthCare Corp | 0.03% | — | — | — | — | — |
| 154 | Arcutis Biotherapeutics Inc | 0.03% | — | — | — | — | — |
| 155 | Ideaya Biosciences Inc | 0.03% | — | — | — | — | — |
| 156 | Prestige Consumer Healthcare Inc | 0.03% | — | — | — | — | — |
| 157 | Waystar Holding Corp | 0.03% | — | — | — | — | — |
| 158 | Dyne Therapeutics Inc | 0.03% | — | — | — | — | — |
| 159 | Arcus Biosciences Inc | 0.03% | — | — | — | — | — |
| 160 | Erasca Inc | 0.03% | — | — | — | — | — |
| 161 | TransMedics Group Inc | 0.03% | — | — | — | — | — |
| 162 | SMMTSummit Therapeutics Inc. Common Stock | 0.03% | $14.00 | -7.3% | -20.0% | -45.5% | $11B |
| 163 | Privia Health Group Inc | 0.03% | — | — | — | — | — |
| 164 | Celldex Therapeutics Inc | 0.03% | — | — | — | — | — |
| 165 | Progyny Inc | 0.03% | — | — | — | — | — |
| 166 | Amneal Pharmaceuticals Inc | 0.03% | — | — | — | — | — |
| 167 | DENTSPLY SIRONA Inc | 0.03% | — | — | — | — | — |
| 168 | Ultragenyx Pharmaceutical Inc | 0.03% | — | — | — | — | — |
| 169 | Immunome Inc | 0.03% | — | — | — | — | — |
| 170 | LeMaitre Vascular Inc | 0.03% | — | — | — | — | — |
| 171 | Acadia Healthcare Co Inc | 0.03% | — | — | — | — | — |
| 172 | Nektar Therapeutics | 0.03% | — | — | — | — | — |
| 173 | Omnicell Inc | 0.03% | — | — | — | — | — |
| 174 | Definium Therapeutics Inc | 0.03% | — | — | — | — | — |
| 175 | Tarsus Pharmaceuticals Inc | 0.03% | — | — | — | — | — |
| 176 | CorVel Corp | 0.03% | — | — | — | — | — |
| 177 | ADMA Biologics Inc | 0.03% | — | — | — | — | — |
| 178 | Neogen Corp | 0.03% | — | — | — | — | — |
| 179 | Pediatrix Medical Group Inc | 0.03% | — | — | — | — | — |
| 180 | BioCryst Pharmaceuticals Inc | 0.03% | — | — | — | — | — |
| 181 | Select Medical Holdings Corp | 0.03% | — | — | — | — | — |
| 182 | Oruka Therapeutics Inc | 0.03% | — | — | — | — | — |
| 183 | Axogen Inc | 0.03% | — | — | — | — | — |
| 184 | Edgewise Therapeutics Inc | 0.03% | — | — | — | — | — |
| 185 | Novocure Ltd | 0.03% | — | — | — | — | — |
| 186 | Intellia Therapeutics Inc | 0.03% | — | — | — | — | — |
| 187 | Relay Therapeutics Inc | 0.03% | — | — | — | — | — |
| 188 | Sarepta Therapeutics Inc | 0.03% | — | — | — | — | — |
| 189 | Kiniksa Pharmaceuticals International Plc | 0.02% | — | — | — | — | — |
| 190 | Adaptive Biotechnologies Corp | 0.02% | — | — | — | — | — |
| 191 | PACS Group Inc | 0.02% | — | — | — | — | — |
| 192 | Aurinia Pharmaceuticals Inc | 0.02% | — | — | — | — | — |
| 193 | Astrana Health Inc | 0.02% | — | — | — | — | — |
| 194 | Addus HomeCare Corp | 0.02% | — | — | — | — | — |
| 195 | Disc Medicine Inc | 0.02% | — | — | — | — | — |
| 196 | Clover Health Investments Corp | 0.02% | — | — | — | — | — |
| 197 | Vericel Corp | 0.02% | — | — | — | — | — |
| 198 | Agios Pharmaceuticals Inc | 0.02% | — | — | — | — | — |
| 199 | UFP Technologies Inc | 0.02% | — | — | — | — | — |
| 200 | Syndax Pharmaceuticals Inc | 0.02% | — | — | — | — | — |
Methodology#
Holdings and weights are sourced from the fund's portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding's price move, keeping the numbers current between filings; positions in stocks ChartRow doesn't track carry their filed weight unchanged and show "—" where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet's GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of VHT?
- VHT's top 10 holdings are Eli Lilly and Company (LLY), 13.8%; Johnson & Johnson (JNJ), 8.8%; AbbVie Inc. (ABBV), 6.3%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 5.1%; Merck & Co. Inc. (MRK), 4.8%; Amgen Inc. (AMGN), 3.2%; Thermo Fisher Scientific Inc. (TMO), 3.2%; Abbott Laboratories (ABT), 2.7%; Gilead Sciences Inc. (GILD), 2.4%; Pfizer Inc. (PFE), 2.2% — together about 52% of the fund, per its May 31, 2026 SEC filing with weights rolled forward to today.
- How many holdings does VHT have?
- Vanguard Health Care ETF (VHT) held 401 positions as of its latest SEC N-PORT filing (May 31, 2026).
- How current are VHT's holdings?
- Funds disclose their full portfolio to the SEC on Form N-PORT; the quarter-end report becomes public about 60 days later. ChartRow anchors on the latest public filing (May 31, 2026) and rolls each weight forward daily by that holding's price move, so the weights shown estimate today rather than the filing date.
- Is ChartRow affiliated with VHT or Vanguard?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by Vanguard or Vanguard Health Care ETF. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.